Financhill
Buy
62

RVMD Quote, Financials, Valuation and Earnings

Last price:
$80.56
Seasonality move :
-4.35%
Day range:
$80.01 - $81.58
52-week range:
$29.17 - $81.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.78x
Volume:
1.1M
Avg. volume:
2.4M
1-year change:
78.3%
Market cap:
$15.6B
Revenue:
--
EPS (TTM):
-$5.18

Earnings Data

Next earnings date for RVMD
Feb 25
2026
Most recent earnings per share
-$1.61
Missed by $0.20
(Nov 5/2025)
Consensus Estimate
-$1.41
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $2.7M -- -- -$1.60 --
11/05/2025 Q3 $1.5M -- -$1.61 -$1.41 -$0.20
08/06/2025 Q2 $27.5M -- -$1.31 -$1.12 -$0.19
05/07/2025 Q1 -- -- -$1.13 -$1.06 -$0.08
02/26/2025 Q4 $346.2K -- -$1.12 -$0.96 -$0.16
11/06/2024 Q3 $346.2K -- -$0.94 -$0.88 -$0.06
08/07/2024 Q2 $807.7K -- -$0.81 -$0.76 -$0.04
05/08/2024 Q1 $674.2K -- -$0.70 -$0.72 $0.01
02/26/2024 Q4 $1.2M $742K -$1.14 -$0.88 -$0.27
11/06/2023 Q3 $857.1K -- -$0.99 -$1.00 $0.01
08/08/2023 Q2 -- $3.8M -$0.92 -- --
05/08/2023 Q1 -- $7M -$0.72 -- --
02/27/2023 Q4 -- $15.3M -$0.63 -- --
11/07/2022 Q3 -- $3.4M -$0.87 -- --
08/09/2022 Q2 -- $9.1M -$0.82 -- --
05/09/2022 Q1 -- $7.6M -$0.78 -- --
02/28/2022 Q4 -- $9.5M -$0.71 -- --
11/10/2021 Q3 -- $1.1M -$0.72 -- --
08/11/2021 Q2 -- $8.7M -$0.60 -- --
05/10/2021 Q1 -- $10.1M -$0.53 -- --
03/02/2021 Q4 -- $8.8M -$0.51 -- --
11/12/2020 Q3 -- $12.7M -$0.42 -- --
08/10/2020 Q2 -- $10M -$0.46 -- --
05/14/2020 Q1 -- $11.5M -$0.37 -- --
12/31/2019 Q4 -- $12.1M -$0.32 -- --
09/30/2019 Q3 -- $12.5M -$0.30 -- --
06/30/2019 Q2 -- $12.3M -$0.23 -- --
03/31/2019 Q1 -- $13.2M -$0.23 -- --
12/31/2018 Q4 -- $10.3M -$0.23 -- --

Revolution Medicines, Inc. Earnings Questions

  • How Much did Revolution Medicines, Inc. Generate in Revenue Last Quarter?

    Revolution Medicines, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Revolution Medicines, Inc. Beat Earnings Last Quarter?

    Revolution Medicines, Inc. announced earnings per share of -$1.61 which represents a miss of analyst forecast a -$1.41 per share.

  • Is Revolution Medicines, Inc. Profitable?

    Revolution Medicines, Inc. reported -$4.3M that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Revolution Medicines, Inc. EPS Next Year?

    Revolution Medicines, Inc.'s earnings are forecast to decrease from -$3.58 per share to -$3.43 per share next year representing a decrease of -54.88%.

  • When is Revolution Medicines, Inc.'s Earnings Date?

    Revolution Medicines, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock